Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Scientific Corporation (BSX) vs Carparts.Com Inc (PRTS) Price & Performance

Boston Scientific CorporationTrade
Carparts.Com IncTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Carparts.Com Inc — how do they compare? Boston Scientific Corporation trades at $43.48 (market cap $66.37B), while Carparts.Com Inc trades at $5.99 (market cap $47.74M). The key difference: Boston Scientific Corporation is far larger — about 1390.2× Carparts.Com Inc's market cap, and Carparts.Com Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.

BSXPRTS
Market Cap
$66.37B$47.74M
Sector
HealthConsumer Cyclical
52-Week High
$108.14$11.40
52-Week Low
$42.63$3.88
Enterprise Value
$75.94B$62.71M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.

BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.

Carparts.Com Inc

CarParts.com (PRTS) trades at $5.66, down 3.58% today, with a bearish technical signal despite recent positive developments including Nasdaq compliance and a $25 million credit facility. The company shows improving operational metrics with three consecutive earnings beats, though it remains unprofitable with negative margins and cash flow. Valuation metrics appear attractive with P/S of 0.07 and P/B of 0.77, but fundamental challenges persist.

While analyst sentiment is positive (60% buy ratings) and recent corporate actions provide stability, PRTS faces significant execution risks amid declining revenue and persistent losses. The stock offers speculative appeal for turnaround investors but requires careful monitoring of cash burn and profitability improvements. Near-term catalysts include Q2 2026 earnings results expected at -$0.85 EPS.

Returns comparison

Trailing returns across standard periods

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS